Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MNCs Discuss China’s Pharmaceutical Market Outlook

This article was originally published in PharmAsia News

Executive Summary

The recent 2008 new pharmaceutical business development forum in Qingdao, China, organized by Pfizer Investment, aimed to provide a platform for exchanging knowledge and analyses for the drug community. Pharmaceutical giants such as Xian-Janssen, Johnson & Johnson, Bayer and Novartis shared their business development strategies and market outlook for China, with participation from McKinsey and PricewaterhouseCoopers. Besides continuing to speed up new drug development, launch and patent application, MNCs are shifting from the previous tradition of setting up plants for production, to pursuing mergers and acquisitions to build a firm foothold in the local market. All seek new collaborative approaches to tap the vast potential of the country, according to forum participants. (Click here for more - Chinese Language)
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066867

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel